Literature DB >> 10567302

Impaired glucose transporter activity in pressure-overload hypertrophy is an early indicator of progression to failure.

I Friehs1, A M Moran, C Stamm, S D Colan, K Takeuchi, H Cao-Danh, C M Rader, F X McGowan, P J del Nido.   

Abstract

BACKGROUND: Severe hypertrophy and heart failure are important risk factors in cardiac surgery. Early adaptive changes in hypertrophy include increased ventricular mass-to-cavity volume ratio (M/V ratio) and increased dependence on glucose for energy metabolism. However, glucose uptake is decreased in the late stages of hypertrophy when ventricular dilatation and failure are present. We hypothesized that impaired glucose uptake would be evident early in the progression of hypertrophy and associated with the onset of ventricular dilatation. METHODS AND
RESULTS: Ten-day-old rabbits underwent banding of the descending aorta. Development of hypertrophy was followed by transthoracic echocardiography to measure left ventricular M/V ratio. Glucose uptake rate, as determined by (31)P-nuclear magnetic resonance spectroscopy measuring 2-deoxyglucose conversion to 2-deoxyglucose-6-phosphate, was measured in isolated perfused hearts obtained from banded rabbits when M/V ratio had increased by 15% from baseline (compensated hypertrophy) and by 30% from baseline (early-decompensated hypertrophy). In age-matched control animals, the rate of glucose uptake was 0.61+/-0.08 micromol x g of wet weight(-1) x 30 min(-1) (mean+/-SEM). With a 15% M/V ratio increase, glucose uptake rate remained at control levels (0.6+/-0.05 micromol x g of wet weight(-1) x 30 min(-1)), compared with hearts with 30% increased M/V ratios, where glucose uptake was significantly lower (0.42+/-0.05 micromol x g of wet weight(-1) x 30 min(-1); P</=0.05). Glucose transporter protein expression was the same in all groups.
CONCLUSIONS: Glucose uptake rate is maintained during compensated hypertrophy. However, coinciding with severe hypertrophy, preceding ventricular dilatation, and glucose transporter protein downregulation, glucose uptake is significantly decreased. Because of the increased dependence of the hypertrophied hearts on glucose use, we speculate that this impairment may be a contributing factor in the progression to failure.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10567302     DOI: 10.1161/01.cir.100.suppl_2.ii-187

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  17 in total

1.  Vascular endothelial growth factor delays onset of failure in pressure-overload hypertrophy through matrix metalloproteinase activation and angiogenesis.

Authors:  I Friehs; R E Margossian; A M Moran; H Cao-Danh; M A Moses; P J del Nido
Journal:  Basic Res Cardiol       Date:  2005-12-23       Impact factor: 17.165

2.  Pressure-overload hypertrophy of the developing heart reveals activation of divergent gene and protein pathways in the left and right ventricular myocardium.

Authors:  Ingeborg Friehs; Douglas B Cowan; Yeong-Hoon Choi; Kendra M Black; Reanne Barnett; Manoj K Bhasin; Christian Daly; Simon J Dillon; Towia A Libermann; Francis X McGowan; Pedro J del Nido; Sidney Levitsky; James D McCully
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-12-21       Impact factor: 4.733

3.  Vascular endothelial growth factor prevents apoptosis and preserves contractile function in hypertrophied infant heart.

Authors:  Ingeborg Friehs; Rodrigo Barillas; Nikolay V Vasilyev; Nathalie Roy; Francis X McGowan; Pedro J del Nido
Journal:  Circulation       Date:  2006-07-04       Impact factor: 29.690

4.  Impaired insulin-signaling in hypertrophied hearts contributes to ischemic injury.

Authors:  Ingeborg Friehs; Hung Cao-Danh; Meena Nathan; Francis X McGowan; Pedro J del Nido
Journal:  Biochem Biophys Res Commun       Date:  2005-05-27       Impact factor: 3.575

Review 5.  Transcriptional regulation of energy substrate metabolism in normal and hypertrophied heart.

Authors:  Rong Tian
Journal:  Curr Hypertens Rep       Date:  2003-12       Impact factor: 5.369

Review 6.  Potential therapeutic benefits of strategies directed to mitochondria.

Authors:  Amadou K S Camara; Edward J Lesnefsky; David F Stowe
Journal:  Antioxid Redox Signal       Date:  2010-08-01       Impact factor: 8.401

7.  Role of oxidative stress in hypertrophied myoblasts stimulated by isoproterenol.

Authors:  Kazuo Itoh; Masahito Minakawa; Yuichi Ono; Takao Tsushima; Kozo Fukui; Ikuo Fukuda
Journal:  Gen Thorac Cardiovasc Surg       Date:  2008-04-10

8.  Phosphate metabolite concentrations and ATP hydrolysis potential in normal and ischaemic hearts.

Authors:  Fan Wu; Eric Y Zhang; Jianyi Zhang; Robert J Bache; Daniel A Beard
Journal:  J Physiol       Date:  2008-07-10       Impact factor: 5.182

9.  Pressure overload induces IL-18 and IL-18R expression, but markedly suppresses IL-18BP expression in a rabbit model. IL-18 potentiates TNF-α-induced cardiomyocyte death.

Authors:  Tadashi Yoshida; Ingeborg Friehs; Srinivas Mummidi; Pedro J del Nido; Solange Addulnour-Nakhoul; Patrice Delafontaine; Anthony J Valente; Bysani Chandrasekar
Journal:  J Mol Cell Cardiol       Date:  2014-08-07       Impact factor: 5.000

10.  Myocardial hypertrophy overrides the angiogenic response to hypoxia.

Authors:  Yeong-Hoon Choi; Douglas B Cowan; Meena Nathan; Dimitrios Poutias; Christof Stamm; Pedro J del Nido; Francis X McGowan
Journal:  PLoS One       Date:  2008-12-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.